SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (145)12/22/2001 5:43:37 PM
From: scaram(o)uche  Read Replies (1) of 897
 
I sold LGND at 17 in 1996 and loudly made the "nothing but dilution for foreseeable future" call. I entered briefly after the mouse studies with a growth factor mimic, losing a few bucks.

So.... as much as I resent the five years of empire building, I agree with Mike and Peter. I feel that J.D.'s comment is a warning, however, for those who might expect above average growth..... even given a nice royalty stream, will Robinson et al. spread any leverage out on more empire?

I would guess that psoriasis isn't built into the share price.

I was surprised to see how well the stock has performed. Last time I looked, it was battling back and forth with single digits.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News